As we know, the ABC DLBCL is characterized with chronic B-cell receptor signaling and activation of NF-κB (Davis et al. 2010, 2001; Havranek et al. 2017; Compagno et al. 2009). The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.